{
    "nct_id": "NCT03164460",
    "official_title": "Phase II Randomized Trial of Stereotactic Onco-Ablative Reirradiation Versus Conventionally Fractionated Conformal Radiotherapy for Patients With Small Inoperable Head and Neck Tumors (SOAR-HN)",
    "inclusion_criteria": "* Patients with histologically documented recurrent head and neck cancer, or second primary head and neck cancer, AND who have previously received radiation (at least 30 Gy) for head and neck cancer\n* Not eligible for surgery for recurrence or poor surgical candidate\n* Gross disease apparent on imaging (magnetic resonance imaging [MRI] or computed tomography [CT])\n* 1-3 sites of recurrence (< 60 cc per site, total volume < 100 cc)\n* Eastern Cooperative Oncology Group (ECOG) = 0, 1, or 2\n* Negative pregnancy test for women of child bearing potential\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients who are pregnant or breast feeding\n* Clinically significant uncontrolled major cardiac, respiratory, renal, hepatic, gastrointestinal or hematologic disease but not limited to:\n\n  * a) Symptomatic congestive heart failure, unstable angina, or cardiac dysrhythmia not controlled by pacer device\n  * b) No myocardial infarction within 3 months of registration\n* Widely metastatic disease (oligometastatic disease acceptable)",
    "miscellaneous_criteria": ""
}